HPV16 variants distribution in invasive cancers of the cervix, vulva, vagina, penis, and anus

Cancer Medicine

Volumn 5, Issue 10, 2016, Pages 2909-2919

  Nicolás Párraga, Sara ^a,b   Gandini, Carolina ^a,b   Pimenoff, Ville N ^a,b   Alemany, Laia ^a,b   de Sanjosé, Silvia ^a,b,c   Xavier Bosch, F ^a,b   Bravo, Ignacio G ^a,d  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d CNRS   (France)

Author keywords

Anogenital cancers; papillomavirus infection and cancer; viral diversity; viral evolution; virus host interactions

Indexed keywords

AGE; ANUS CANCER; ARTICLE; ASIA; CANCER DIAGNOSIS; CENTRAL AMERICA; E6 GENE; EUROPE; GENE FREQUENCY; GENETIC POLYMORPHISM; GEOGRAPHIC ORIGIN; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTH AMERICA; TREND STUDY; TUMOR INVASION; UTERINE CERVIX CANCER; VAGINA CANCER; VIRUS GENE; VULVA CANCER; ANUS TUMOR; CLASSIFICATION; COMPLICATION; FEMALE; GENETICS; MALE; PAPILLOMAVIRIDAE; PENIS TUMOR; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX TUMOR; VAGINA TUMOR; VIROLOGY; VULVA TUMOR;

E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

ANUS NEOPLASMS; ASIA; CENTRAL AMERICA; EUROPE; FEMALE; HUMANS; MALE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; SOUTH AMERICA; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 84992474620     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.870     Document Type: Article

References (46)

1. IARC. 2012. IARC monographs on the evaluation of carcinogenic risks to humans - biological agents. 100B:100B.
2. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518–527.
3. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, et al. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12–19.
4. de Sanjose, S., W. G. Quint, L. Alemany, D. T. Geraets, J. E. Klaustermeier, B. Lloveras, et al. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 11:1048–1056.
5. De Vuyst, H., G. M. Clifford, M. C. Nascimento, M. M. Madeleine, and S. Franceschi. 2009. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int. J. Cancer 124:1626–1636.
6. Alemany, L., A. Cubilla, G. Halec, E. Kasamatsu, B. Quirós, E. Masferrer, et al. 2016. Role of human papillomavirus in penile carcinomas Worldwide. Eur. Urol.
7. Giuliano, A. R., G. Tortolero-Luna, E. Ferrer, A. N. Burchell, S. de Sanjose, S. K. Kjaer, et al. 2008. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26(Suppl 1):K17–K28.
8. Alemany, L., M. Saunier, I. Alvarado-Cabrero, B. Quirós, J. Salmeron, H.-R. Shin, et al. 2015. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int. J. Cancer 136:98–107.
9. de Sanjosé, S., L. Alemany, J. Ordi, S. Tous, M. Alejo, S. M. Bigby, et al. 2013. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur. J. Cancer 49:3450–3461.
10. Alemany, L., M. Saunier, L. Tinoco, B. Quirós, I. Alvarado-Cabrero, M. Alejo, et al. 2014. Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur. J. Cancer 50:2846–2854.
11. Bruni, L., M. Diaz, X. Castellsague, E. Ferrer, F. X. Bosch, and S. de Sanjose. 2010. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J. Infect. Dis. 202:1789–1799.
12. Bzhalava, D., P. Guan, S. Franceschi, J. Dillner, and G. Clifford. 2013. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology 445:224–231.
13. Bravo, I. G., and M. Félez-Sánchez. 2015. Papillomaviruses: viral evolution, cancer and evolutionary medicine. Evol. Med. Public Health 2015:32–51.
14. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. Zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17–27.
15. Burk, R. D., A. Harari, and Z. Chen. 2013. Human papillomavirus genome variants. Virology 445:232–243.
16. Cornet, I., T. Gheit, S. Franceschi, J. Vignat, R. D. Burk, B. S. Sylla, et al. 2012. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J. Virol. 86:6855–6861.
17. Grodzki, M., G. Besson, C. Clavel, A. Arslan, S. Franceschi, P. Birembaut, et al. 2006. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol. Biomarkers Prev. 15:820–822.
18. Gheit, T., I. Cornet, G. M. Clifford, T. Iftner, C. Munk, M. Tommasino, et al. 2011. Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiol. Biomarkers Prev. 20:1315–1321.
19. Stark, M., S. A. Berger, A. Stamatakis, and C. von Mering. 2010. MLTreeMap–accurate maximum likelihood placement of environmental DNA sequences into taxonomic and functional reference phylogenies. BMC Genom. 11:461.
20. Berger, S. A., and A. Stamatakis. 2011. Aligning short reads to reference alignments and trees. Bioinformatics 27:2068–2075.
21. Stamatakis, A. 2006. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22:2688–2690.
22. Pattengale, N. D., A. J. Aberer, K. M. Swenson, A. Stamatakis, and B. M. E. Moret. 2011. Uncovering hidden phylogenetic consensus in large data sets. IEEE/ACM Trans Comput Biol Bioinform [Internet] 8:902–911. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21301032 (accessed: September 30, 2015)
23. Larsson, G. L., G. Helenius, S. Andersson, F. Elgh, B. Sorbe, and M. G. Karlsson. 2012. Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden. Int. J. Gynecol. Cancer 22:1413–1419.
24. Yamada, T., C. M. Wheeler, A. L. Halpern, A. C. Stewart, A. Hildesheim, and S. A. Jenison. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 69:7743–7753.
25. Ho, L., S. Y. Chan, V. Chow, T. Chong, S. K. Tay, L. L. Villa, et al. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J. Clin. Microbiol. 29:1765–1772.
26. Larsson, G. L., G. Helenius, S. Andersson, B. Sorbe, and M. G. Karlsson. 2013. Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma. Gynecol. Oncol. 129:406–411.
27. de Koning, M. N. C., W. G. V. Quint, and E. C. Pirog. 2008. Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma. Mod. Pathol. 21:334–344.
28. Ouhoummane, N., M. Steben, F. Coutlée, T. Vuong, P. Forest, C. Rodier, et al. 2013. Squamous anal cancer: patient characteristics and HPV type distribution. Cancer Epidemiol. 37:807–812.
29. Tornesello, M. L., M. L. Duraturo, S. Losito, G. Botti, S. Pilotti, B. Stefanon, et al. 2008. Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int. J. Cancer 122:132–137.
30. López-Romero, R., C. Iglesias-Chiesa, B. Alatorre, K. Vázquez, P. Piña-Sánchez, I. Alvarado, et al. 2013. HPV frequency in penile carcinoma of Mexican patients: important contribution of HPV16 European variant. Int. J. Clin. Exp. Pathol. 6:1409–1415.
31. Villa, L. L., L. Sichero, P. Rahal, O. Caballero, A. Ferenczy, T. Rohan, et al. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 81:2959–2968.
32. Zuna, R. E., E. Tuller, N. Wentzensen, C. Mathews, R. A. Allen, R. Shanesmith, et al. 2011. HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer. Infect. Agent Cancer 6:19.
33. Cornet, I., T. Gheit, M. R. Iannacone, J. Vignat, B. S. Sylla, A. Del Mistro, et al. 2013. HPV16 genetic variation and the development of cervical cancer worldwide. Br. J. Cancer 108:240–244.
34. Freitas, L. B., Z. Chen, E. F. Muqui, N. A. T. Boldrini, A. E. Miranda, L. C. Spano, et al. 2014. Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. PLoS ONE 9:e100746.
35. Lopera, E. A., A. Baena, V. Florez, J. Montiel, C. Duque, T. Ramirez, et al. 2014. Unexpected inverse correlation between Native American ancestry and Asian American variants of HPV16 in admixed Colombian cervical cancer cases. Infect. Genet. Evol. 28:339–348.
36. Banister, C. E., A. R. Messersmith, B. Cai, L. B. Spiryda, S. H. Glover, L. Pirisi, et al. 2015. Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age. J. Infect. Dis. 211:100–108.
37. Amador-Molina, A., J. L. González-Montoya, A. García-Carrancá, A. Mohar, and M. Lizano. 2013. Intratypic changes of the E1 gene and the long control region affect ori function of human papillomavirus type 18 variants. J. Gen. Virol. 94:393–402.
38. Zehbe, I., C. Richard, C. A. DeCarlo, A. Shai, P. F. Lambert, H. Lichtig, et al. 2009. Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 383:69–77.
39. Zehbe, I., H. Lichtig, A. Westerback, P. F. Lambert, M. Tommasino, and L. Sherman. 2011. Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential. Mol. Cancer. 10:77.
40. Zehbe, I., E. Wilander, H. Delius, and M. Tommasino. 1998. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58:829–833.
41. Tornesello, M. L., S. Losito, G. Benincasa, F. Fulciniti, G. Botti, S. Greggi, et al. 2011. Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol. Oncol. 121:32–42.
42. Crum, C. P. 2000. Contemporary theories of cervical carcinogenesis: the virus, the host, and the stem cell. Mod. Pathol. 13:243–251.
43. Herfs, M., Y. Yamamoto, A. Laury, X. Wang, M. R. Nucci, M. E. McLaughlin-Drubin, et al. 2012. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc. Natl Acad. Sci. USA 109:10516–10521.
44. Yang, E. J., M. C. Quick, S. Hanamornroongruang, K. Lai, L. A. Doyle, F. D. McKeon, et al. 2015. Microanatomy of the cervical and anorectal squamocolumnar junctions: a proposed model for anatomical differences in HPV-related cancer risk. Mod. Pathol. 28:994–1000. Available from: http://dx.doi.org/10.1038/modpathol.2015.54 (accessed 27 September 2015)
45. The 1000 genomes project consortium. 2012. An integrated map of genetic variation from 1092 human genomes. Nature 491:56–65.
46. Homburger, J. R., A. Moreno-Estrada, C. R. Gignoux, D. Nelson, E. Sanchez, P. Ortiz-Tello, et al. 2015. Genomic insights into the ancestry and demographic history of South America. PLoS Genet. 11:e1005602.